Hereditary Hemochromatosis, DNA
A one-time genetic test for HFE gene variants causing hereditary hemochromatosis — the body absorbing and storing too much iron.
One of the most common genetic disorders in people of Northern European descent, and one of the most treatable — if caught early. Untreated iron overload damages liver, heart, pancreas and joints irreversibly.
What did your HFE result show?
What to do next. The actionable numbers are ferritin and transferrin saturation, not the gene. Saturation above roughly 45% with a raised ferritin warrants proper assessment. Anyone with a C282Y homozygous result should never take supplemental iron and should avoid high-dose vitamin C with meals, which increases absorption. Treatment — venesection — is simple, effective and needs a clinician.
What Hereditary Hemochromatosis, DNA actually measures — the analyte, and the assay
This is not a blood chemistry and it does not measure iron. It is a targeted genotyping assay run on DNA from an EDTA tube or a buccal swab, looking at two positions in the HFE gene on chromosome 6 and, on some panels, a third: p.C282Y (c.845G>A), which disrupts a disulfide bond the protein needs to reach the cell surface; p.H63D (c.187C>G); and sometimes p.S65C. The chemistry is PCR with allele-specific probes, melting-curve discrimination or a TaqMan-style readout.
Targeted means exactly that. The assay interrogates those positions and nowhere else. It cannot see the non-HFE iron-overload genes — HJV, HAMP, TFR2 and the ferroportin gene SLC40A1 — and it cannot see secondary overload from transfusion or ineffective erythropoiesis. A negative HFE panel is reassurance about two mutations, not about iron Anderson 2021.
The result is a genotype, so the analytical accuracy is close to perfect and the interpretive uncertainty is close to total. Almost no other test on this site has that shape. Genotyping error rates are vanishingly small; the entire difficulty is that carrying the genotype and having the disease are two different states, and the assay reports only the first Anderson 2021.
Mechanistically, HFE sits with transferrin receptor 2 in the hepatocyte as part of the sensor that sets hepcidin output. Lose the sensor and hepcidin runs too low for the body's iron load, ferroportin stays in the enterocyte membrane, and absorption continues when it should have stopped. That is the whole disease in one sentence — and it also explains why the phenotype takes decades to build.
Hereditary Hemochromatosis, DNA: what changes the blood, and what only changes the reading
Nothing changes the analyte. It is your germline and it was fixed at conception. That makes this page structurally different from every other marker page here, and it means the ranked list below is not about the test result at all — it is about the phenotype, which is what the genotype does or does not become.
What changes whether a C282Y homozygote ever loads iron:
- Sex, and it is the largest single modifier. In UK Biobank, hemochromatosis was diagnosed in 21.7% (281/1294) of male C282Y homozygotes and 9.8% (156/1596) of female ones Pilling 2019. Menstruation and pregnancy are, in iron terms, decades of phlebotomy.
- Time. Penetrance is not a fixed percentage — it keeps climbing. Following the same cohort to age 80, baseline diagnoses at a mean age of 57 were 12.1% of homozygous men, but the cumulative incidence reached 56.4% by age 80; in women the figures were 3.4% and 40.5% Lucas 2024.
- Blood loss of any kind, deliberate or otherwise. A regular donor is treating a condition they may not know they have.
- Alcohol and hepatic steatosis, which compound iron's effect on the liver rather than adding to it.
- Modifier genotype. Two copies of C282Y is the high-risk combination; compound heterozygosity with H63D is much weaker, and H63D alone is not an iron-overload genotype Anderson 2021.
What changes only the reading — a short list, because a genotype has few ways to be wrong:
- Which variants the panel covers. A two-variant panel and a three-variant panel do not answer the same question.
- Sample identity. With a qualitative result there is no plausibility check — nothing about a genotype looks wrong, so a mislabeled tube cannot be caught by the result.
- The interpretive error, which dwarfs both: reading heterozygosity as disease. Single-copy carriage is common — with two copies found in 0.6% of a European-ancestry cohort Pilling 2019, allele arithmetic puts carriers near one person in seven — and a carrier's ferritin of 500 ng/mL is far more likely to be metabolic or inflammatory than genetic Valenti 2023 Luo 2023.
Reference interval or decision threshold — which kind of number Hereditary Hemochromatosis, DNA is
Neither. A genotype has no range — the result is a category, and the number that should be printed next to it is not a reference interval but a penetrance.
Penetrance is the number this page exists to give you, and it is not one number. Two copies of p.C282Y is common: 2,890 people, or 0.6% — about 1 in 156 — in a single large cohort Pilling 2019. What follows from it depends entirely on how long you look. Diagnosed hemochromatosis in that cohort was 21.7% of homozygous men at recruitment Pilling 2019; followed to 80, the cumulative incidence was 56.4% in men and 40.5% in women Lucas 2024.
And the outcomes attached to the genotype are real, which is the argument for knowing. By age 80, C282Y homozygotes had 27.9% versus 17.1% joint replacements and 20.3% versus 8.3% liver disease against those with no HFE variants, with all-cause death in 33.1% versus 25.4% (hazard ratio 1.29, 95% CI 1.12 to 1.48, p = 4.7×10⁻⁴) Lucas 2024. Those are outcome-anchored figures of exactly the kind most ‘optimal range’ claims lack.
The numbers that do behave like thresholds sit on the other two tests. A transferrin saturation persistently at or above 45% and a raised ferritin are the phenotype screen; the genotype explains a positive screen and does not replace it Sandnes 2021 Mahant 2023.
How you would know your Hereditary Hemochromatosis, DNA was wrong — and when to redraw
The genotype is never retested. The phenotype is retested forever. That distinction is the whole of the follow-up plan, and the page's own retest line — ‘never, fixed for life’ — is right about the DNA and silent about the part that matters.
The biological reason for the monitoring interval is the loading rate. Excess absorption in an unmanaged homozygote runs at a few milligrams a day against a normal one to two, so the surplus accumulates over decades, not months — which is precisely why the cumulative incidence curve keeps climbing to age 80 Lucas 2024. An annual ferritin with a transferrin saturation is a fast enough sampling rate for a process that slow.
Conditions that must match for serial phenotype monitoring: the same laboratory and TIBC method Mahant 2023; a fasted morning draw with no iron supplement for 24 hours; no acute illness; and an hs-CRP alongside, because inflammation raises ferritin and lowers transferrin at the same time and can manufacture a picture that looks like loading Luo 2023.
What would have to change for the follow-up to mean something. A genotype cannot be proven wrong, but the inference drawn from it can, in both directions:
- Homozygous, with a normal ferritin and a saturation under 45% year after year? You are in the majority of homozygotes at that age who have not expressed the phenotype Pilling 2019.
- Homozygous with ferritin and saturation both rising? That is loading, and the confirmatory markers are the iron panel and the CMP for hepatic involvement.
- Not homozygous but ferritin high? The genotype has excluded one explanation and left the commoner ones standing — check the saturation, and if it is normal, read the pattern as metabolic Valenti 2023.
- Ferritin falling on phlebotomy? Watch the CBC: the endpoint of treatment is iron depletion without anemia, and it is easy to overshoot.
What Hereditary Hemochromatosis, DNA cannot tell you
It cannot tell you whether you have iron overload. It tells you whether you have a genotype associated with a risk of it. Nearly eight in ten homozygous men in a middle-aged cohort had no hemochromatosis diagnosis at recruitment Pilling 2019, and a majority in the same cohort did by 80 Lucas 2024 — the same genotype, two very different sentences, separated only by follow-up time.
A negative result does not exclude iron overload. Non-HFE hereditary forms and every secondary cause — transfusion, ineffective erythropoiesis, chronic liver disease — are invisible to this panel Anderson 2021.
Heterozygosity is not a diagnosis and is not a partial diagnosis. A single C282Y copy is common, and using it to explain a raised ferritin stops the workup at the wrong place: the far likelier explanations are inflammation, alcohol and metabolic dysfunction Sandnes 2021 Valenti 2023.
It cannot stage organ damage. Whether iron has reached the liver or the heart is an imaging question — T2* MRI — and no genotype and no ferritin answers it.
The wrong inference readers actually draw runs in both directions and the second one is the expensive one. Some read a homozygous result as a sentence and start donating blood on a schedule nobody set, watching a ferritin fall past the point of usefulness. Others read a heterozygous result as an explanation for a ferritin of 600 ng/mL and never check the saturation that would have told them it was 24% Valenti 2023.
Sources read for these sections
- Pilling LC, et al. Common conditions associated with hereditary haemochromatosis genetic variants: cohort study in UK Biobank. BMJ 2019 · PMID 30651232
- Lucas MR, et al. HFE genotypes, haemochromatosis diagnosis and clinical outcomes at age 80 years: a prospective cohort study in the UK Biobank. BMJ Open 2024 · PMID 38479735
- Anderson GJ, et al. Revisiting hemochromatosis: genetic vs. phenotypic manifestations. Annals of Translational Medicine 2021 · PMID 33987429
- Sandnes M, et al. Hyperferritinemia-A Clinical Overview. Journal of Clinical Medicine 2021 · PMID 34067164
- Valenti L, et al. Consensus Statement on the definition and classification of metabolic hyperferritinaemia. Nature Reviews Endocrinology 2023 · PMID 36805052
- Mahant H, et al. Appropriate Method of TIBC Estimation in Reference to Serum Transferrin Levels. Journal of Laboratory Physicians 2023 · PMID 37064980
- Luo H, et al. A Practical Guide to Adjust Micronutrient Biomarkers for Inflammation Using the BRINDA Method. Journal of Nutrition 2023 · PMID 36792034
The plan of attack
In this order. Most people start at step four, which is why they change five things at once and learn nothing.
- Confirm the number is real
Nothing physiological affects the genotype. Fixed for life. Iron studies fluctuate constantly with inflammation, supplements and recent meals; the genotype does not move at all. Test once and never repeat it — then monitor ferritin and saturation instead, because those are the numbers that change. - Read it with its partner
Test if ferritin and transferrin saturation are persistently high. This is a genuine 'find it and fix it' condition. Draw it alongside: Ferritin, Iron Panel (Iron, TIBC, Transferrin Saturation), Comprehensive Metabolic Panel (CMP). - Work out which direction is yours
If it's high — Homozygous C282Y carries the highest risk. Treatment is simple and effective — therapeutic phlebotomy — which is exactly why finding it early matters so much.
If it's low — Normal. - Fix it in this order
Nutrition. If confirmed: avoid iron supplements and vitamin C with iron-rich meals (it boosts absorption), limit alcohol (compounds liver damage), and avoid raw shellfish (infection risk with iron overload).
Lifestyle. Regular therapeutic phlebotomy per your physician — highly effective and prevents essentially all complications when started early.
Supplements. Avoid all iron supplementation. Avoid high-dose vitamin C with meals.
Hormones. Not hormonal. Monitor liver function and consider hepatology referral.
Compounds. Ironically, TRT users who donate blood for hematocrit control get incidental protection — but that doesn't replace diagnosis.
Work down the list, not across it. Adding a compound on top of an unfixed diet is why generic protocols fail. - Retest
Never — fixed for life. Change one thing at a time, or the retest can't tell you which thing worked.
How to fix it
📚 Feder JN et al., Nat Genet 1996 — HFE gene discovery. EASL Clinical Practice Guidelines on hemochromatosis.
This page can tell you what could have made your Hereditary Hemochromatosis, DNA wrong. It cannot tell you whether it did.
Everything above is free and stays free — the assay, what changes the reading rather than the blood, the retest window and the sources. What no page can do is look at your draw: which laboratory ran it, at what hour, what you were taking that week, and what else was flagged beside it. Every one of those changes the answer, and none of them is on any page. Bringing a real result to people who know that list is what the members' area is for.
Bring your result — $10/mo →🩸 Test your Hereditary Hemochromatosis, DNA
Order directly through Marek Diagnostics — no doctor's visit needed, drawn at any Quest location in the US. Code CAMERON applies 10% off automatically.
Order this test — 10% off → Browse all 103 markers →What Hereditary Hemochromatosis, DNA is usually tested alongside
One marker is a data point. These panels add the markers that make Hereditary Hemochromatosis, DNA interpretable, name why each is on the list, and load the set into your cart at 10% off.
includes this + 7 more markers — Anyone whose iron saturation came back above about 45%, anyone with a high ferritin that did not settle when the inflammation did, and anyone with a parent or sibling already diagnosed with hereditary hemochromatosis.
includes this + 4 more markers — You want the handful of genetic results that actually change what you do — tested once, never repeated.
What people use Hereditary Hemochromatosis, DNA to decide
Nobody orders a test for its own sake. Hereditary Hemochromatosis, DNA is on the test list for these pathways — each one links to what the pathway claims, and what its test list is read for before you spend anything on it.
Before assuming toxins, rule out the two inherited causes of liver injury that are common and completely missable: hemochromatosis (iron) and Wilson's disease (copper). Both are one test each.
Every nutrient here is harmful in excess as well as in deficiency, which is exactly why guessing is the wrong move. Iron and iodine are the two that most reliably hurt people who supplement them without looking first.
What moves your Hereditary Hemochromatosis, DNA
2 supplements in the Vault have a documented effect on this marker, or are a reason to have measured it first:
Browse all 278 compounds & 371 supplements →
Would you feel it? Symptoms Hereditary Hemochromatosis, DNA helps explain
People search for how they feel, not for a marker. These are the complaints where this one is worth checking, and whether it is first-line or a follow-up.
Why your Hereditary Hemochromatosis, DNA might be wrong
Most abnormal results are interference, not disease. Check these before you change anything. Each says whether the number is wrong (repeat it), badly timed (redraw it), or real with a cause.
Fixed for life. Iron studies fluctuate constantly with inflammation, supplements and recent meals; the genotype does not move at all.
Test once and never repeat it — then monitor ferritin and saturation instead, because those are the numbers that change.
Two copies of C282Y is common in Northern European ancestry, but only a minority develop clinical iron overload — and it is less penetrant in women, who lose iron through menstruation.
A positive genotype is a reason to monitor ferritin and transferrin saturation, not a diagnosis of iron overload.
Genetics tells you the risk; ferritin and saturation tell you whether it has happened. High iron studies with a negative genotype still needs explaining.
Read both together. Neither replaces the other.
What Hereditary Hemochromatosis, DNA means in combination
One marker tells you a little; combinations tell you the story. These are the named patterns this one takes part in.
Common and much less alarming than it reads. Only a minority of people with two copies develop clinical iron overload, and penetrance is lower in women, who lose iron through menstruation. The genotype is a risk, not a diagnosis.
Monitor ferritin and transferrin saturation periodically rather than acting on the genotype. And never take iron supplements without testing.
What to test next
These put Hereditary Hemochromatosis, DNA in context — each with its own full breakdown.
Frequently asked questions
Result: normal, heterozygous, or homozygous (C282Y, H63D). Ranges vary by laboratory and assay — always compare to the range printed on your own report.
No variants.
Homozygous C282Y carries the highest risk. Treatment is simple and effective — therapeutic phlebotomy — which is exactly why finding it early matters so much.
Normal.
You can order Hereditary Hemochromatosis, DNA directly through Marek Diagnostics without a doctor's visit — drawn at any Quest Diagnostics location in the US. Code CAMERON applies 10% off automatically.
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.